Israel’s SciVac Eyes Global Expansion of 3G Hepatitis B Vaccine

The majority of Israeli children are given SciVac’s hepatitis B vaccine not long after birth. The company is about to embark on a clinical trial of the vaccine in the U.S. with an eye to receiving FDA approval.
Reuters